Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): an open-label, multicentre, randomised trial.
Welzel T., Atkinson A., Schöbi N., Andre M.C., Bailey DGN, Blanchard-Rohner G., Buettcher M., Grazioli S., Koehler H., Perez M.H. et al., 2023/04. The Lancet. Child & adolescent health, 7 (4) pp. 238-248. Peer-reviewed.
ici le détail